Progressive Care Subsidiary ClearMetrX Launches 340MetrX Platform to Help Streamline 340B Program and Increase Claim Capture
06 Octobre 2022 - 2:20PM
InvestorsHub NewsWire
MIAMI, FL -- October 6, 2022 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:RXMD)
(“Progressive Care” or the “Company”), a personalized healthcare
services and technology company, is excited to announce the launch
of its 340Metrx Platform to help 340B covered entities increase the
number of 340B qualified claims and program savings while
supporting compliance efforts.
The 340MetrX platform is a software product developed by the
Company’s wholly-owned subsidiary ClearMetrX that provides
340B-covered entities with data insights to effectively operate and
maximize the benefits of the 340B program. The platform allows
program administrators to manage, in real time, data related to
revenue, virtual inventory, drug replenishment and reconciliation,
detailed prescription history analysis, customized ordering data
with major wholesalers, patient information, drug prescribing
trends, and customized financial breakdowns. The software analyzes
claim records and provides a complete overview of the financial
health of the entity while diminishing the number of ineligible
claims through the 340MetrX automated review process.
The 340MetrX software enhances the existing third-party
administration services ClearMetrX is currently providing to
entities by complementing in-house 340B experts with a robust
reporting platform aiming to maximize the limited resources in the
340B space through identification and validation of missing claims,
increasing the covered entity’s revenue.
“340MetrX allows our data analytics processes to be
significantly more productive, giving our team an ability to
seamlessly manage data for a much greater number of 340B entities
in Florida, with potential to be scaled nationwide. According to
data from Berkeley Research Group Industry Roundtable Report, 340B
gross sales across the program are expected to grow from $116B in
2021 to $280B in 2026. We intend to take full advantage of the
momentum this sector presents and are excited to now offer
customers in every part of our country a solution that allows them
to reduce efforts related to compliance and risk mitigation,
strengthen the potential to capture more revenue, and simplify the
whole 340B process,” stated Alan Jay Weisberg, CEO of Progressive
Care Inc.
For more information about Progressive Care, please visit the
Company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
Progressivecareus.com
PharmCoRx Pharmacy
Pharmcorx.com
ClearMetrx
Clearmetrx.com
About Progressive Care
Progressive Care Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
Forward-Looking Statements:
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company’s
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
When used herein, the words “anticipate,” “believe,” “estimate,”
“upcoming,” “plan,” “target,” “intend” and “expect” and similar
expressions, as they relate to Progressive Care Inc., its
subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company’s actual results, performance, prospects,
and opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Progressive Care (QB) (USOTC:RXMD)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Progressive Care (QB) (USOTC:RXMD)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024